Association between Epstein-Barr virus infection and chemoresistance to docetaxel in gastric carcinoma
- 154 Downloads
Epstein-Barr virus (EBV) is associated with human cancers such as nasopharyngeal carcinoma, Burkitt’s lymphoma, Hodgkin’s disease, and gastric carcinoma (GC). EBV is associated with about 10% of all GC cases globally. EBV-associated GC has distinct features from EBV-negative GC. However, it is still unclear if EBV infection has any effect on GC chemoresistance. Cell proliferation assay, cell cycle analysis, and active caspase Western blot revealed that the EBV-positive GC cell line (AGS-EBV) showed chemoresistance to docetaxel compared to the EBV-negative GC cell line (AGS). Docetaxel treatment increased expression of Bax similarly in AGS and AGS-EBV cell lines. However, Bcl-2 induction was markedly higher in AGS-EBV cells, after docetaxel treatment. Although docetaxel increased the expression of p53 to a similar extent in both cell lines, induction of p21 in AGS-EBV cells was lower than in AGS cells. Furthermore, expression of survivin was higher in AGS-EBV cells than in AGS cells following docetaxel treatment as well as at basal state. EBVlytic gene expression was induced by docetaxel treatment in AGS-EBV cells. The results suggest that EBV infection and lytic induction confers chemoresistance to GC, possibly by regulating cellular and EBV latent and lytic gene expression.
Keywordsapoptosis cell cycle related genes chemoresistance docetaxel EBV-positive gastric carcinoma
Unable to display preview. Download preview PDF.
- Daibata, M., Bandobashi, K., Kuroda, M., Imai, S., Miyoshi, I., and Taguchi, H. (2005). Induction of lytic Epstein-Barr virus (EBV) infection by synergistic action of rituximab and dexamethasone renders EBV-positive lymphoma cells more susceptible to ganciclovir cytotoxicity in vitro and in vivo. J. Virol. 79, 5875–5879.PubMedCrossRefGoogle Scholar
- Hino, R., Uozaki, H., Murakami, N., Ushiku, T., Shinozaki, A., Ishikawa, S., Morikawa, T., Nakaya, T., Sakatani, T., Takada, K., et al. (2009). Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma. Cancer Res. 69, 2766–2774.PubMedCrossRefGoogle Scholar
- Imai, S., Koizumi, S., Sugiura, M., Tokunaga, M., Uemura, Y., Yamamoto, N., Tanaka, S., Sato, E., and Osato, T. (1994). Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc. Natl. Acad. Sci. USA 91, 9131–9135.PubMedCrossRefGoogle Scholar
- Jung, E.J., Lee, Y.M., Lee, B.L., Chang, M.S., and Kim, W.H. (2007a). Ganciclovir augments the lytic induction and apoptosis induced by chemotherapeutic agents in an Epstein-Barr virusinfected gastric carcinoma cell line. Anticancer Drugs 18, 79–85.Google Scholar
- Lu, J., Murakami, M., Verma, S.C., Cai, Q., Haldar, S., Kaul, R., Wasik, M.A., Middeldorp, J., and Robertson, E.S. (2011). Epstein-Barr Virus nuclear antigen 1 (EBNA1) confers resistance to apoptosis in EBV-positive B-lymphoma cells through up-regulation of survivin. Virology 410, 64–75.PubMedCrossRefGoogle Scholar
- Mei, Y.P., Zhou, J.M., Wang, Y., Huang, H., Deng, R., Feng, G.K., Zeng, Y.X., and Zhu, X.F. (2007). Silencing of LMP1 induces cell cycle arrest and enhances chemosensitivity through inhibition of AKT signaling pathway in EBV-positive nasopharyngeal carcinoma cells. Cell Cycle 6, 1379–1385.PubMedCrossRefGoogle Scholar
- Oh, S.T., Seo, J.S., Moon, U.Y., Kang, K.H., Shin, D.J., Yoon, S.K., Kim, W.H., Park, J.G., and Lee, S.K. (2004). A naturally derived gastric cancer cell line shows latency I Epstein-Barr virus infection closely resembling EBV-associated gastric cancer. Virology 320, 330–336.PubMedCrossRefGoogle Scholar
- Rickinson, A.B., and Kieff, E.(2001). Epstein-Barr virus. In Field’s Virology, B.M. Knipe, and P.M. Howley, eds. (Philadelphia, USA: Lippincott Williams and Wilkins), pp. 2575–2627.Google Scholar
- van Beek, J., zur Hausen, A., Kranenbarg, E.K., Warring, R.J., Bloemena, E., Craanen, M.E., van de Velde, C.J., Middeldorp, J.M., Meijer, C.J., and van den Brule, A.J. (2002). A rapid and reliable enzyme immunoassay PCR-based screening method to identify EBV-carrying gastric carcinomas. Mod. Pathol. 15, 870–877.PubMedCrossRefGoogle Scholar
- Vicat, J.M., Ardila-Osorio, H., Khabir, A., Brezak, M.C., Viossat, I., Kasprzyk, P., Jlidi, R., Opolon, P., Ooka, T., Prevost, G., et al. (2003). Apoptosis and TRAF-1 cleavage in Epstein-Barr viruspositive nasopharyngeal carcinoma cells treated with doxorubicin combined with a farnesyl-transferase inhibitor. Biochem. Pharmacol. 65, 423–433.PubMedCrossRefGoogle Scholar